FIELD: medical science.
SUBSTANCE: invention refers to medicine, particularly to psychopharmacology. Disclosed is use of peptide Ac-His-Ala-Glu-Glu-NH2 with an N-terminal acetyl group and a C-terminal amide group (HAEE), or pharmaceutically acceptable salts thereof, or complexes thereof for restoring a physiologically normal concentration of endogenous HAEE in the blood in mental disorders and behavioural disorders.
EFFECT: invention enables restoring the physiologically normal concentration of endogenous HAEE in the blood in mental disorders and behaviour disorders characterized by a drop in the level of endogenous HAEE in the blood as compared to the norm.
2 cl, 1 dwg, 5 tbl, 4 ex
